Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03543293
Other study ID # 6807
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 20, 2018
Est. completion date February 2019

Study information

Verified date February 2018
Source University Hospital, Strasbourg, France
Contact Francis VEILLON, MD, PhD
Phone 33 3 88 12 78 65
Email Francis.veillon@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Our objective is to validate the CT / MRI combination of non-injected rock for the rapid positive diagnosis of perilymphatic fistulas.


Recruitment information / eligibility

Status Recruiting
Enrollment 101
Est. completion date February 2019
Est. primary completion date February 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age greater than or equal to 18

- Clinical suspicion of perilymphatic fistula

- Patient having undergone a rock scan or MRI of the middle ear at the Strasbourg University Hospital with surgical confirmation of the diagnosis (or reversal)

Exclusion Criteria:

- Refusal of the patient to participate in the study

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Service Imagerie 1 Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnosis of perilymphatic fistula 1 hour after surgery